New DNA and RNA aptamers offer unique therapeutic advantages

New Rochelle, NY, August 5, 2009 -- A novel class of drugs composed of single strands of DNA or RNA, called aptamers, can bind protein targets with a high strength and specificity and are currently in clinical development as treatments for a broad range of common diseases, as described in a comprehensive review article published online ahead of print in Oligonucleotides, a peer-reviewed

Read the whole article on Science Blog

More from Science Blog